The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levine, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levine, S. J.
The Journal of Immunology, 2004, 173: 5343-5348.
Copyright © 2004 by The American Association of Immunologists


BRIEF REVIEWS

Mechanisms of Soluble Cytokine Receptor Generation

Stewart J. Levine1

Pulmonary-Critical Care Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892

Soluble cytokine receptors regulate inflammatory and immune events by functioning as agonists or antagonists of cytokine signaling. As such, they act within complex receptor systems that include signaling receptors, nonsignaling decoy receptors, receptor-associated proteins, and soluble receptor antagonists. Soluble cytokine receptors can be generated by several mechanisms, which include proteolytic cleavage of receptor ectodomains, alternative splicing of mRNA transcripts, transcription of distinct genes that encode soluble cytokine-binding proteins, release of full-length receptors within the context of exosome-like vesicles, and cleavage of GPI-anchored receptors. Furthermore, the important role of soluble cytokine receptors in regulating host defense mechanisms is evidenced by viruses that encode soluble homologues of mammalian receptors and thereby evade innate host immune responses via the sequestration of essential cytokines.




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. Horiuchi, H. Morioka, H. Takaishi, H. Akiyama, C. P. Blobel, and Y. Toyama
Ectodomain Shedding of FLT3 Ligand Is Mediated by TNF-{alpha} Converting Enzyme
J. Immunol., June 15, 2009; 182(12): 7408 - 7414.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Horiuchi, T. Kimura, T. Miyamoto, K. Miyamoto, H. Akiyama, H. Takaishi, H. Morioka, T. Nakamura, Y. Okada, C. P. Blobel, et al.
Conditional Inactivation of TACE by a Sox9 Promoter Leads to Osteoporosis and Increased Granulopoiesis via Dysregulation of IL-17 and G-CSF
J. Immunol., February 15, 2009; 182(4): 2093 - 2101.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. Doucet, G. S. Butler, D. Rodriguez, A. Prudova, and C. M. Overall
Metadegradomics: Toward in Vivo Quantitative Degradomics of Proteolytic Post-translational Modifications of the Cancer Proteome
Mol. Cell. Proteomics, October 1, 2008; 7(10): 1925 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Z. Tiran, A. Oren, C. Hermesh, G. Rotman, Z. Levine, H. Amitai, T. Handelsman, M. Beiman, A. Chen, D. Landesman-Milo, et al.
A Novel Recombinant Soluble Splice Variant of Met Is a Potent Antagonist of the Hepatocyte Growth Factor/Scatter Factor-Met Pathway
Clin. Cancer Res., July 15, 2008; 14(14): 4612 - 4621.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. J. Levine
Molecular Mechanisms of Soluble Cytokine Receptor Generation
J. Biol. Chem., May 23, 2008; 283(21): 14177 - 14181.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Saposnik, E. Lesteven, A. Lokajczyk, C. T. Esmon, M. Aiach, and S. Gandrille
Alternative mRNA is favored by the A3 haplotype of the EPCR gene PROCR and generates a novel soluble form of EPCR in plasma
Blood, April 1, 2008; 111(7): 3442 - 3451.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. G. McDonald, K. Yang, H. R. Roberts, D. M. Monroe, and M. Hoffman
Perivascular tissue factor is down-regulated following cutaneous wounding: implications for bleeding in hemophilia
Blood, February 15, 2008; 111(4): 2046 - 2048.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Lebbink, M. C. W. van den Berg, T. de Ruiter, N. Raynal, J. A. G. van Roon, P. J. Lenting, B. Jin, and L. Meyaard
The Soluble Leukocyte-Associated Ig-Like Receptor (LAIR)-2 Antagonizes the Collagen/LAIR-1 Inhibitory Immune Interaction
J. Immunol., February 1, 2008; 180(3): 1662 - 1669.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Vranjkovic, A. M. Crawley, K. Gee, A. Kumar, and J. B. Angel
IL-7 decreases IL-7 receptor {alpha} (CD127) expression and induces the shedding of CD127 by human CD8+ T cells
Int. Immunol., December 1, 2007; 19(12): 1329 - 1339.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. C. Deregibus, V. Cantaluppi, R. Calogero, M. Lo Iacono, C. Tetta, L. Biancone, S. Bruno, B. Bussolati, and G. Camussi
Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA
Blood, October 1, 2007; 110(7): 2440 - 2448.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Hayakawa, M. Hayakawa, A. Kume, and S.-i. Tominaga
Soluble ST2 Blocks Interleukin-33 Signaling in Allergic Airway Inflammation
J. Biol. Chem., September 7, 2007; 282(36): 26369 - 26380.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Bulanova, V. Budagian, E. Duitman, Z. Orinska, H. Krause, R. Ruckert, N. Reiling, and S. Bulfone-Paus
Soluble Interleukin (IL)-15R{alpha} Is Generated by Alternative Splicing or Proteolytic Cleavage and Forms Functional Complexes with IL-15
J. Biol. Chem., May 4, 2007; 282(18): 13167 - 13179.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-S. Zhang, S. A. Anderson, K. R. Meyers, C. Hernandez, R. S. Eisenstein, and C. A. Enns
Evidence That Inhibition of Hemojuvelin Shedding in Response to Iron Is Mediated through Neogenin
J. Biol. Chem., April 27, 2007; 282(17): 12547 - 12556.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
S. N. Prince, E. J. Foulstone, O. J. Zaccheo, C. Williams, and A. B. Hassan
Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor
Mol. Cancer Ther., February 1, 2007; 6(2): 607 - 617.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Diveu, E. Venereau, J. Froger, E. Ravon, L. Grimaud, F. Rousseau, S. Chevalier, and H. Gascan
Molecular and Functional Characterization of a Soluble Form of Oncostatin M/Interleukin-31 Shared Receptor
J. Biol. Chem., December 1, 2006; 281(48): 36673 - 36682.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Tabata, W. Chen, M. R. Warrier, A. M. Gibson, M. O. Daines, and G. K. K. Hershey
Allergy-Driven Alternative Splicing of IL-13 Receptor {alpha}2 Yields Distinct Membrane and Soluble Forms
J. Immunol., December 1, 2006; 177(11): 7905 - 7912.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Bamias, M. Mishina, M. Nyce, W. G. Ross, G. Kollias, J. Rivera-Nieves, T. T. Pizarro, and F. Cominelli
From the Cover: Role of TL1A and its receptor DR3 in two models of chronic murine ileitis
PNAS, May 30, 2006; 103(22): 8441 - 8446.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. L. Webster, K. Kedzierska, R. Azzam, G. Paukovics, J. Wilson, S. M. Crowe, and A. Jaworowski
Phagocytosis stimulates mobilization and shedding of intracellular CD16A in human monocytes and macrophages: inhibition by HIV-1 infection
J. Leukoc. Biol., February 1, 2006; 79(2): 294 - 302.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-S. Zhang, A. P. West Jr., A. E. Wyman, P. J. Bjorkman, and C. A. Enns
Interaction of Hemojuvelin with Neogenin Results in Iron Accumulation in Human Embryonic Kidney 293 Cells
J. Biol. Chem., October 7, 2005; 280(40): 33885 - 33894.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
E. W. Raines and N. Ferri
Thematic Review Series: The Immune System and Atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease
J. Lipid Res., June 1, 2005; 46(6): 1081 - 1092.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.